Pok-Ja Oh1, Jung-Ran Cho. 1. Author Affiliations: Department of Nursing (Dr Oh); Department of Nursing, Graduate School (Ms Cho), Sahmyook University, Seoul, Korea.
Abstract
BACKGROUND: Chemotherapy leads to various symptoms and psychological distress, which contribute to a significant decrease in the quality of life of the patients. OBJECTIVES: The aim of this study was to identify changes and interrelationships in the fatigue-depression-anxiety symptom cluster and quality of life during the cancer care trajectory in women with breast cancer. METHODS: Fifty women participated in the study and completed questionnaires at 3 different times: prechemotherapy, postchemotherapy, and 6 months after the completion of chemotherapy. The assessment tools were the Functional Assessment of Cancer Therapy-Fatigue Scale, Hospital Anxiety and Depression Scale, and Functional Assessment of Cancer Therapy-Breast Cancer version 4 Scale. Data were analyzed using descriptive and repeated-measures analysis of variance statistics. RESULTS: A significant increase in fatigue (F = 41.95, P < .001) and psychological distress (F = 26.55, P < .001) from prechemotherapy to postchemotherapy was noted. Improvement was observed 6 months after the completion of chemotherapy. A positive or negative change in fatigue was associated with the same in psychological distress. Quality of life (F = 65.22, P < .001) also showed similar change patterns as observed with fatigue and psychological distress. Fatigue had a greater impact on quality of life at postchemotherapy, but psychological distress had a greater impact at prechemotherapy and at the 6-month follow-up. CONCLUSION: These results suggest that chemotherapy is highly associated with the fatigue-depression-anxiety symptom cluster and quality of life in women with breast cancer. IMPLICATIONS FOR PRACTICE: Nursing intervention is needed to relieve the intensity of the fatigue-depression-anxiety symptom cluster and thus improve the quality of life of patients undergoing chemotherapy from before treatment to follow-up.
BACKGROUND: Chemotherapy leads to various symptoms and psychological distress, which contribute to a significant decrease in the quality of life of the patients. OBJECTIVES: The aim of this study was to identify changes and interrelationships in the fatigue-depression-anxiety symptom cluster and quality of life during the cancer care trajectory in women with breast cancer. METHODS: Fifty women participated in the study and completed questionnaires at 3 different times: prechemotherapy, postchemotherapy, and 6 months after the completion of chemotherapy. The assessment tools were the Functional Assessment of Cancer Therapy-Fatigue Scale, Hospital Anxiety and Depression Scale, and Functional Assessment of Cancer Therapy-Breast Cancer version 4 Scale. Data were analyzed using descriptive and repeated-measures analysis of variance statistics. RESULTS: A significant increase in fatigue (F = 41.95, P < .001) and psychological distress (F = 26.55, P < .001) from prechemotherapy to postchemotherapy was noted. Improvement was observed 6 months after the completion of chemotherapy. A positive or negative change in fatigue was associated with the same in psychological distress. Quality of life (F = 65.22, P < .001) also showed similar change patterns as observed with fatigue and psychological distress. Fatigue had a greater impact on quality of life at postchemotherapy, but psychological distress had a greater impact at prechemotherapy and at the 6-month follow-up. CONCLUSION: These results suggest that chemotherapy is highly associated with the fatigue-depression-anxiety symptom cluster and quality of life in women with breast cancer. IMPLICATIONS FOR PRACTICE: Nursing intervention is needed to relieve the intensity of the fatigue-depression-anxiety symptom cluster and thus improve the quality of life of patients undergoing chemotherapy from before treatment to follow-up.
Authors: Joseph M Gullett; Ronald A Cohen; Gee Su Yang; Victoria S Menzies; Robert A Fieo; Debra L Kelly; Angela R Starkweather; Colleen K Jackson-Cook; Debra E Lyon Journal: Psychooncology Date: 2019-03-14 Impact factor: 3.894
Authors: Megan E Renna; M Rosie Shrout; Annelise A Madison; Maryam Lustberg; Stephen P Povoski; Doreen M Agnese; Raquel E Reinbolt; Robert Wesolowski; Nicole O Williams; Bhuvaneswari Ramaswamy; Sagar D Sardesai; Anne M Noonan; Jeffrey B VanDeusen; William B Malarkey; Janice K Kiecolt-Glaser Journal: J Behav Med Date: 2020-11-01
Authors: Julie A Meade; Alison N Fowlkes; Mackinsey J Wood; Mary Claire Kurtz; Madeline M May; Wisam B Toma; Urszula O Warncke; Jared Mann; Mohammed Mustafa; Aron H Lichtman; M Imad Damaj Journal: Behav Pharmacol Date: 2021-08-01 Impact factor: 2.277
Authors: Urszula O Warncke; Wisam Toma; Julie A Meade; Abigail J Park; Danielle C Thompson; Martial Caillaud; John W Bigbee; Camron D Bryant; M Imad Damaj Journal: Front Pain Res (Lausanne) Date: 2021-07-22
Authors: Kathleen Iles; Mya L Roberson; Philip Spanheimer; Kristalyn Gallagher; David W Ollila; Paula D Strassle; Stephanie Downs-Canner Journal: NPJ Breast Cancer Date: 2022-03-01
Authors: Macarena C Cáceres; Marta Nadal-Delgado; Casimiro López-Jurado; Demetrio Pérez-Civantos; Jorge Guerrero-Martín; Noelia Durán-Gómez Journal: Int J Environ Res Public Health Date: 2022-03-16 Impact factor: 4.614